Lexicon Pharmaceuticals Reports 2nd Quarter Financial Results, Provides Clinical Pipeline Update
Go back to Lexicon Pharmaceuticals Reports 2nd Quarter Financial Results, Provides Clinical Pipeline Update| Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) | Delayed: 2.16 +0.01 (0.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.15 | 52 Week High | $19.62 | |||
| Open | $2.10 | 52 Week Low | $7.65 | |||
| Day High | $2.19 | P/E | N/A | |||
| Day Low | $2.06 | EPS | $-0.22 | |||
| Volume | 325,481 | |||||
